Skip to primary navigation Skip to main content
0 item $0.00

Extracellular vesicles (EVs) are secreted membrane-enclosed nano-sized particles (40–1,000 nm) that deliver biological information between cells. The molecular composition of these subcellular particles includes growth factor receptors, ligands adhesion proteins, mRNA, miRNAs, lncRNA and lipids that are derived from donor cells. A number of studies demonstrated that stem cell-derived EVs are the key mediator of tissue repair and regeneration in multiple animal disease models. In addition, the composition of these particles is known to be altered in cancer and disease pathology suggesting them for useful in diagnostic and therapeutic purposes. Their endogenous origin and biological properties offer benefits over conventional drug delivery systems (DDS), such as liposome, synthetic nanoparticles and prompted the further application of EVs as drug delivery vehicles for chemical drugs, genetic materials and proteins. The contents of EVs can be efficiently modified by chemical, biological or physical means.

This project will investigate how specific biological payloads in nano-carriers alter target cell landscape, through combination of mass spectrometry applied to understand the proteome. Phosphoproteome and lipidome networks. Informatic tools will be central in focusing key regulatory components in various cell systems. This understanding will provide new knowledge on reprogramming target cells in cardiovascular disease.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more